HOLX · As filed with the SEC
Hologic income statement, by fiscal year
The statement as Hologic presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Income · USD, except per-share amounts; shares in thousands
| USD, except per-share amounts; shares in thousands | FY2025 Year ended Sep 27, 2025 | FY2024 Year ended Sep 28, 2024 | FY2023 Year ended Sep 30, 2023 | FY2022 Year ended Sep 24, 2022 |
|---|---|---|---|---|
| Revenues: | ||||
| Revenue from product and services | 4,100,500,000 | 4,030,300,000 | 4,030,400,000 | 4,862,800,000 |
| Product | 3,256,100,000 | 3,255,100,000 | 3,279,900,000 | 4,191,200,000 |
| Service | 844,400,000 | 775,200,000 | 750,500,000 | 671,600,000 |
| Costs of revenues: | ||||
| Product | — | 1,206,200,000 | 1,184,300,000 | 1,166,100,000 |
| Service | — | 376,600,000 | 389,400,000 | 386,200,000 |
| Product | 1,246,400,000 | — | — | — |
| Service | 376,300,000 | — | — | — |
| Amortization of acquired intangible assets | 176,500,000 | 180,500,000 | 205,700,000 | 295,700,000 |
| Impairment of intangible assets and equipment | 183,400,000 | 39,200,000 | 179,500,000 | 17,400,000 |
| Gross profit | 2,117,900,000 | 2,227,800,000 | 2,071,500,000 | 2,997,400,000 |
| Operating expenses: | ||||
| Research and development | 248,200,000 | 272,800,000 | 294,300,000 | 283,400,000 |
| Selling and marketing | 620,600,000 | 585,400,000 | 595,200,000 | 630,300,000 |
| General and administrative | 449,300,000 | 409,400,000 | 392,400,000 | 407,700,000 |
| Amortization of acquired intangible assets | 14,400,000 | 29,200,000 | 28,100,000 | 45,200,000 |
| Impairment of intangible assets and equipment | — | — | 44,300,000 | 27,700,000 |
| Impairment of intangible assets and equipment | 42,500,000 | 5,600,000 | — | — |
| Contingent consideration fair value adjustments | 0 | 1,700,000 | (14,900,000) | (39,500,000) |
| Loss on assets held-for-sale | 0 | 0 | 51,700,000 | — |
| Restructuring charges | 28,600,000 | 41,100,000 | 12,000,000 | 2,400,000 |
| Operating expenses | 1,403,600,000 | 1,345,200,000 | 1,403,100,000 | 1,357,200,000 |
| Income from operations | 714,300,000 | 882,600,000 | 668,400,000 | 1,640,200,000 |
| Interest income | 74,400,000 | 108,700,000 | 120,500,000 | 12,900,000 |
| Interest expense | — | (122,100,000) | (111,100,000) | (95,100,000) |
| Debt extinguishment loss | — | 0 | 0 | (700,000) |
| Interest expense | (117,100,000) | — | — | — |
| Other income (expense), net | 9,600,000 | (4,100,000) | (1,700,000) | 30,900,000 |
| Income before income taxes | 681,200,000 | 865,100,000 | 676,100,000 | 1,588,200,000 |
| Provision for income taxes | 115,500,000 | 75,600,000 | 220,100,000 | 286,200,000 |
| Net income | — | — | 456,000,000 | 1,302,000,000 |
| Comprehensive loss attributable to noncontrolling interest | — | — | 0 | — |
| Net income | 565,700,000 | 789,500,000 | 456,000,000 | 1,302,000,000 |
| Net income per common share: | ||||
| Basic (in dollars per share) | 2.50 | 3.35 | 1.85 | 5.18 |
| Diluted (in dollars per share) | 2.49 | 3.32 | 1.83 | 5.13 |
| Weighted average number of shares outstanding: | ||||
| Basic (in shares) | 226,156 | 235,723 | 246,772 | 251,527 |
| Diluted (in shares) | 227,573 | 237,553 | 248,831 | 253,845 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.